Latest Breaking News On - Dbio thera - Page 1 : comparemela.com

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, announced that its partner Biogen recently received notification from the United States Food and Drug Administration (FDA) on the approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. The TOFIDENCE intravenous formulation is approved for the treatment of moderately to severely active rheuma

Hong kongUnited statesWechat bio theraShengfeng liBiogen incBio thera solutionsBio thera solutions ltdDisease modifying anti rheumatic drugsJuvenile idiopathic arthritisImportant safety informationThera solutionsRheumatoid arthritisJuvenile idiopathic arthritisPharmaceutical companyMonoclonal antibodyDbio thera